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Background/Aims: We examined the ischemia-modified albumin (IMA) level during  exercise in patients with coronary 
artery  disease  (CAD).
Methods: Forty patients with a history of chest pain underwent both symptom-limited treadmill exercise stress testing 
and  coronary  angiography  within  one  week.  During  the  treadmill  tests,  blood  samples  were  obtained  at  baseline  and 
5  min  after  exercise  to  measure  the  serum  IMA  level.
Results: Of the 40 patients, fourteen (35%, CAD group) had significant coronary artery stenosis, while the other 26 
(65%, non-CAD group) did not. The baseline and post-exercise IMA levels in the two groups did not differ significantly 
(105.2±7.2  vs.  107.7±6.7  U/mL  at  baseline  and  93.1±10.1  vs.  94.8±5.7  U/mL  at  post-exercise  in  the  CAD  and 
non-CAD groups, p=0.29 and 0.57, respectively). The changes in IMA after exercise did not differ either (-10.4±7.5 vs. 
-14.0±7.6  U/mL  in  the  CAD  and  non-CAD  groups,  respectively,  p=0. 1 0 ) .  S i m i l a r l y ,  t h e  c h a n g e  i n  I M A  b e t w e e n  t h e  
exercise ECG test positive (TMT positive, n=9) and negative (TMT negative, n=20) groups did not differ (-14.63±5.19, 
vs  -8.50±9.01  U/mL,  p=0.15,  in  the  TMT  positive  and  negative  groups,  respectively).
Conclusions:  Our  results  suggest  that  IMA  has  limitation  in  detecting  myocardial  ischemia  during  symptom-limited 
exercise  stress  tests.
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INTRODUCTION
Ischemia-modified  albumin  (IMA)  has  emerged  as  a  useful 
diagnostic  modality  for  evaluating  chest  pain,  especially  in 
patients  with  acute  coronary  syndrome
1).  During  an  ischemic 
attack, a lack of oxygen in localized areas of the heart induces 
a  series  of  reactions  involving  free  radicals  leading  to  an 
N-terminal  structural  change  in  albumin,  producing  IMA
2). 
Recently,  several  studies  reported  a  high  negative  predictive 
value  and  high  sensitivity  for  detecting  patients  with  acute 
coronary  syndrome  presenting  to  the  emergency  department 
with  chest  pain
3-7).  Other  studies  demonstrated  that  the  serum 
l e v e l  o f  I M A  i n c r e a s e d  r a p i d l y  a f t e r  t r a n s i e n t  b a l l o o n  o c c l u s i o n 
during  percutaneous  coronary  intervention  (PCI)
8-10).  In  contrast, 
some  studies  have  suggested  that  the  change  in  IMA  in 
response  to ischemia in organs other  than  the  heart  is  not  the 
same  as  that  in  ischemic  myocardium,  such  as  in  skeletal 
muscle  ischemia  and  bowel  ischemia
11, 12).  In  reality,  most 
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not resting pain. Several studies have examined the meaning of 
serum  IMA  in  exercise-induced  myocardial  ischemia  and 
reported  that  IMA  was  not  useful  for  identifying  myocardial 
ischemia  during  exercise
13, 14);  however,  most  of  these  studies 
used non-invasive tests, such as exercise stress tests, to provide 
evidence  of  myocardial  ischemia.  Such  non-invasive  tests  are 
limited  in  their  ability  to  address  the  issue  because  of  false 
positive or negative results. Thus, in this study, we examined the 
meaning  of  the  IMA  level  during  exercise  with  greater  precision 
by  performing  both  exercise  ECG  testing  and  coronary 
angiography.
MATERIALS AND METHODS
The subjects included 40 patients with a history of chest pain. 
Patients  with  the  following  conditions  were  excluded  from  the 
s t u dy :  ( 1)  l e g c l a u di c a t i on;  ( 2)  a  hi s t or y  of  my oc a r di a l  i nf a r ction; 
(3)  a  recent  (within  four  weeks)  history  of  PCI;  (4)  a  history  of 
stroke;  (5)  renal  insufficiency  (serum  creatinine  ≥  2  mg/dL);  (6) 
cancer  or  other  active  inflammation;  and  (7)  baseline  ECG 
abnormalities that might complicate the interpretation of exercise 
ECG  test  results,  such  as  a  left  bundle  branch  block, 
Wolff-Parkinson-White  syndrome,  and  ST  depression.  All  of  the 
patients  underwent  both  symptom-limited  treadmill  exercise 
stress testing and coronary angiography within one week. During 
the treadmill tests, blood samples were obtained at baseline and 
5  min  after  exercise  to  measure  the  serum  IMA  and  lactate 
levels.
Treadmill  Exercise  Stress  Test  (TMT)
All  of  the  patients  underwent  symptom-limited  treadmill 
exercise  ECG  testing  using  the  Bruce  protocol
13).  The  test  was 
terminated if the patient complained of fatigue, marked dyspnea, 
exercise-limiting  angina,  dizziness  with  a  documented  systolic 
blood  pressure  drop  of  more  than  20  mmHg,  or  marked 
ST-segment  depression  (>  3  mm).  The  exercise  ECGs  were 
interpreted  by  an  independent  physician.  The  patients  were 
declared  positive  for  myocardial  ischemia  i f  t h e y  s h o w e d  ≥  
1-mm horizontal or down-sloping ST-segment depression at 80 
ms  after  the  J-point  during  the  exercise  or  recovery  period.  If 
they  showed  no  significant  ST-segment  change,  the  patients 
were declared negative for myocardial ischemia or placed in the 
indeterminate group depending on whether their heart rate (HR) 
reached more than 85% of the estimated maximum value. Blood 
samples were obtained before exercise (baseline) and 5 min after 
the  cessation  of  exercise.  The  patients  were  assigned  to  the 
TMT  positive  or  negative  group  according  to  their  TMT  result.
Coronary  Angiography
Coronary angiography was performed within one week of the 
exercise treadmill test. The femoral or radial artery was used as 
the puncture site.  Quantitative coronary angiography (QCA) was 
used to determine the degree of stenosis in the major branches 
of  the  coronary  arteries.  If  a  narrowing  lesion  with  ≥  50% 
stenosis  was  detected  by  QCA,  coronary  artery  disease  (CAD) 
with  significant  stenosis  was  deemed  present.  Patients  were 
assigned  to  the  CAD  or  non-CAD  group  according  to  whether 
they  had  significant  CAD  on  the  coronary  angiogram.
Analysis  of  Blood  Samples
Blood  was  collected  in  Vacutainer  tubes  (Becton  Dickinson, 
Franklin Lakes, NJ, USA). The samples were frozen at -70 °C 
within  2  h  and  stored  until  analysis.  Serum  IMA  was  measured 
using  the  Albumin  Cobalt  Binding  (ACB)  Test  (Ischemia 
Technologies,  Denver,  CO,  USA)  using  a  Synchron  LX20 
chemical  autoanalyzer  (Beckman  Coulter,  Fullerton,  CA,  USA). 
The  total  intra-assay  coefficient  of  variation  (CV)  was  2.36～
3.29%  while  the  inter-assay  CV  was  3.01～6.35%  at  55-132 
U/mL  for  the  quality-control  materials.  The  lactic  acid  con-
centration  was  measured  using  a  Nova  M7.
Data  Analysis
The  serum  IMA  and  lactate  levels  before  and  after  exercise 
were  compared  in  both  the  CAD/non-CAD  groups  and  the 
TMT-positive/-negative  groups.
Statistical  Analysis
Student’s  t-t e s t  w a s  u s e d  t o  c o mp a r e  c o n t i n u o u s  v a r i a b l e s  
(expressed  as  the  mean±SD).  For  discrete  variables,  χ
2 
analysis  was  used.  For  non-parametric  testing,  the  Mann- 
W h i t n e y  U - t e s t  w a s  u s e d  t o  c o m p a r e  c o n t i n u o u s  v a r i a b l e s  i n  
two  groups.  All  p-values  less  than  0.05  were  considered 
statistically  significant.
RESULTS
Coronary  Angiography
O f  t h e  4 0  p a t i e n t s ,  2 6  s h o w e d  no  significant  narrowing  (the 
non-CAD  group)  whereas  the  other  fourteen  patients  showed 
evidence  of  significant  stenosis  in  at  least  one  coronary  artery 
(the CAD group). Age, sex, and the proportion of risk factors for 
CAD did not differ between the two groups. In the CAD group, 
nine patients (64.3%) had 1-vessel disease, two patients (14.3%) 
had  2-vessel  disease,  and  three  patients  (21.4%)  had  3-vessel 
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Non-CAD  group
n=26
CAD  group
n=14
p
Age
Male:Female  (%)
Risk  factor
  H y p e r t e n s i o n
    Diabetes  mellitus
  S m o k i n g
    Hypercholesterolemia
Coronary  artery  disease
  1-vessel  disease  (n,  %)
    2-vessel  disease  (n,  %)
    3-vessel  disease  (n,  %)
57.8±9.9
12(46.2)
6  (23.1)
4  (15.4)
10  (38.5)
7  (26.9)
66.1±9.2
7(50)
5  (35.7)
3  (21.4)
5  (35.7)
4  (28.6)
9  (64.3)
2  (14.3)
3  (21.4)
0.058
0.816
0.393
0.631
0.864
0.911
CAD,  coronary  artery  disease
Table  1.  Clinical  characteristics  of  the  patients
 N o n - C A D  g r o u p
(n=26)
CAD  group
(n=14)
p
METs  achieved
Maximum  HR
Actual  maximum  HR  compared  to  the  predicted  maximum  HR  (%)
Achieved  ≥  85%  of  the  predicted  maximum  HR
P o s i t i v e  E C G  ( n ,  % )
A c h i e v e d  ≥  8 5 %  o f  t h e  p r e d i c t e d  m a x i m u m  H R  o r  p o s i t i v e  E C G  ( n ,  %)
8.4±2.4
139.5±19
87.0±9.8
18  (69.2)
1  (3.8)
19  (73.1)
7.4±1.74
126.9±20.5
87.2±13.6
8  (57.1)
8  (57.1)
10  (71.4)
0.22
0.07
0.18
0.445
0.001
0.911
HR,  heart  rate;  ECG,  electrocardiogram;  CAD,  coronary  artery  disease;  METs,  metabolic  equivalents
Table  2.  Results  of  the  exercise  ECG  test
Exercise  ECG  Testing
During  the  exercise  ECG  test,  the  metabolic  equivalents 
(METs) achieved were 7.4±1.7 in the CAD group and 8.4±2.4 
in the non-CAD group (p=0.22) (Table 2). Eight patients (57.1%) 
i n  t h e  C A D  g r o u p  a n d  1 8  p a t i e n t s  ( 6 9 . 2 % )  i n  t h e  n o n - C A D  
group (p=0.18) achieved ≥ 85% of the predicted maximum HR. 
The  proportion  of  patients  who  achieved  ≥  85%  of  the 
predicted  maximum  HR  or  a  positive  ECG  change  during 
exercise,  which  constituted  sufficient  stress  to  determine  the 
ischemic  response,  did  not  differ  between  the  CAD  and 
non-CAD  groups  (71.4  vs.  73.1%,  respectively,  p=0.91)  (Table 
2).  Positive  exercise  ECG  tests  (TMT  positive)  were  obtained  in 
eight patients (57.1%) in the CAD group, but in only one patient 
(3.8%)  in  the non-CAD group  (p=0.001).  Twenty  patients  (50%) 
had  negative  results  on  the  exercise  ECG  test  (TMT  negative, 
Table  3).
Laboratory  Results
Serum  IMA  level
The  baseline  and  post-exercise  IMA  values  did  not  differ 
significantly between the  CAD and non-CAD groups (105.2±7.2 
vs.  107.7±6.7  U/mL  at  baseline  and  93.1±10.1  vs.  94.8±5.7 
U/mL post-exercise, p=0.29 and 0.57, respectively; Table 4 and 
F i g u r e  1 ) .  T h e  c h a n g e s  i n  I M A  a f t e r  e x e r c i s e  w a s  n o t  d i f f e r e n t  
b e t w e e n  t h e  C A D  o r   n o n - C A D  g r o u p s  ( - 1 0 . 4 ± 7 . 5  v s .  
-14.0±7.6 U/mL, p=0.10) (Figure 1). In only two cases (5%), did 
the post-exercise IMA level increase compared with the baseline 
value.  The  serum  IMA  concentration  was  also  analyzed 
according to the results of the treadmill exercise ECG test. The 
b a s e l i n e  s e r u m  I M A  c o n c e n t r a t i o n s  d i d  n o t  d i f f e r  b e t w e e n  t h e  
TMT negative (n=20) and positive (n=9) groups (107.79±7.01 vs. 
105.25±8.94,  p=0.62)  (Table  4).  Neither  did  the  post-exercise 
IMA  values  (93.15±9.60  vs.  96.75±6.25  mM  in  the  TMT 
n e g a t i v e  a n d  p o s i t i v e  g r o u p s ,  p=0.42).  The  change  in  the  IMA 
concentration  during  exercise  was  not  different  either 
(-14.63±5.19  vs.  -8.50±9.01  mM  in  the  respective  groups, 
p=0.15)  (Table  4,  Figure  2).
Serum  lactate  level
The  baseline  and  post-exercise  lactate  levels  did  not  differ 
s i g n i f i c a n t l y  b e t w e e n  t h e  C A D  a n d  n o n - C A D  g r o u p s  ( 2 . 8 ± 1 . 1  
v s .  2 . 8 ± 0 . 8  m M  a t  b a s e l i n e  a n d  7 . 5 ± 2 . 6  v s .  6 . 0 ± 2 . 3  m M  
post-exercise, p=0.29 and 0.51, respectively) (Table 4, Figure 1). 
The  changes  in  the  lactate  level  after  exercise  did  not  differ 
either  (3.2±2.3  vs.  4.7±2.5  U/mL,  p=0.08).  When  the  serum 
lactate values were analyzed according to the exercise ECG test 
results,  the  baseline  and  post-exercise  lactate  levels  did  not 
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TMT-negative  group
(n=20)
TMT-positive  group
(n=9)
p
Age 
Male  (%)
METs  achieved
Actual  maximum  HR  compared  to  the  predicted  maximum  HR
57.5±10.9
10  (50)
8.7±2.4
89.7±7.9
67.3±9.2
3  (33.3)
7.4±1.5
90.9±12.1
0.03
0.39
0.12
0.78
Table  3.  Characteristics  of  the  TMT-positive  and  -negative  groups
 N o n - C A D  G r o u p
(n=26)
CAD  Group
(n=14)
p
(t-test)
p
Baseline  IMA  (U/mL)
Post-exercise  IMA
ΔIMA
Baseline  lactate  (mM)
Post-exercise  lactate
ΔLactate
107.65±6.67
93.12±10.11
-14.5±7.25
2.83±0.77
7.49±2.58
4.67±2.51
105.21±7.24
94.79±5.7
-10.43±7.46
2.83±1.09
6.03±2.34
3.2±2.31
0.29
0.57
0.10
1.00
0.09
0.08
<  0.001*
<  0.001†
 T M T - n e g a t i v e
(n=20) 
TMT-positive
(n=9)
pp
Baseline  IMA  (U/mL)
Post-exercise  IMA
ΔIMA
Baseline  lactate  (mM)
Post-exercise  lactate
ΔLactate
107.79±7.01
93.15±9.60
-14.63±5.19
2.91±0.77
7.92±2.52
5.00±2.62
105.25±8.94
96.75±6.25
-8.50±9.01
2.89±1.35
6.20±2.32
3.31±2.67
0.62
0.42
0.15
0.33
0.06
0.13
 <  0 . 0 0 1 *
 <  0 . 0 0 1 †
*  p-value  for  baseline  IMA  vs.  post-exercise  IMA  for  each  group
†p-value  for  baseline  lactate  vs.  post-exercise  lactate  for  each  group
IMA=ischemia-modified  albumin
ΔIMA=post-exercise  IMA  -  baseline  IMA
ΔLactate=post-exercise  lactate  -  baseline  lactate
Table  4.  Serum  IMA  and  lactate  levels  at  baseline  and  post-exercise
Figure 1. C hanges in IM A  and lacta te from  baseline to post- exercise.
groups  (Table  4).
Correlation  between  the  serum  IMA  and  lactate  levels
T h e  s e r u m I MA  l e v e l  w a s  s t r on gl y  c or r e l a t e d  w i t h  t h e  s e r u m 
lactate level (r=-0.71, p<0.01). The change in the IMA level was 
also significantly correlated with the change in the serum lactate 
level  (r=-0.61,  p< 0 . 0 1 )  ( F i g u r e  3 ) .
DISCUSSION
IMA  is  produced  by  free  radicals  from  albumin  when  the 
myocardium is in an ischemic state
2, 16). This has been validated 
by several studies using human ischemic myocardial models with 
transient balloon occlusion of the coronary artery during PCI
8-10). 
In  fact,  the  serum  IMA  level  is  so  sensitive  to  myocardial 
ischemia that the level increases even when the level of troponin 
stays  within  normal  limit.  This  means  that  IMA  can  be  used  as 
a  marker  of  reversible  myocardial  ischemia.  According  to  a 
previous  report
8),  immediately  following  2-3  min  of  balloon 
occlusion  of  the  coronary  artery,  18  of  19  patients  (94.7%) 
showed  elevated  levels  of  IMA.  Several  studies  have  also 
suggested  that  if  the  IMA  level  is  considered  with  concomitant 
ECG  changes  in  the  case  of  acute  coronary  syndrome,  the 
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Figure 2. Changes in serum IMA at baseline and post-exercise
according to the results of the exercise ECG test.
Figure  3.  Correlation  between  the  changes  in  IMA  and  lactate  after 
symptom-limited  exercise.
studies,  measurement  of  IMA  can  be  used  at  admission,  in 
combination with measurement of cardiac troponin and ECG, to 
confirm  or  exclude  a  final  diagnosis  of  ischemic  heart  disease 
and  to  exclude  myocardial  infarction
1, 7).
While  minimal-effort  or  resting  chest  pain  remains  the  main 
complaint  in  patients  with  acute  coronary  syndrome,  effort- 
related  chest  pain  is  the  main  symptom  of  stable  angina. 
However,  the  usefulness  of  IMA  in  identifying  effort-related 
myocardial  ischemia  was  unclear  until  a  number  of  recent 
studies  reported  no  specific  relationship  between  IMA  plasma 
levels and coronary ischemia during exercise
13, 14). In fact, several 
studies have cast doubt on the usefulness of plasma IMA in the 
setting of myocardial ischemia during exercise. A recent report
14) 
showed  that  the  IMA  level  was  significantly  reduced  during 
exercise,  and  it  was  suggested  that  hemoconcentration  with  a 
subsequent increase in the plasma albumin level during exercise 
was responsible for the decrease in the non-bound portion at a 
fixed level of cobalt stress. It has also been suggested that the 
elevated plasma IMA levels seen during myocardial ischemia are 
ultimately  caused  by  other  mechanisms,  such  as 
hemoconcentration
13).    We  also  found  that  the  serum  IMA  level 
dropped significantly right after exercise in both groups, which is 
consistent  with  these  previous  results
13,14).  W h e n  t h e  c h a n g e  i n  
the  serum  IMA  level  (ΔIMA)  was  analyzed  according  to  the 
res ul t s  of  t he ex erci s e ECG t es t , ΔI MA duri ng exer ci se di d not 
differ significantly between the TMT positive and negative groups. 
Similarly, it was reported that there was no interaction between 
∆IMA  and  the  results  of  a  stress  test
13).  I n  t h a t  s t u d y ,  b l o o d  
samples  were  collected  before  the  stress  test  (baseline),  at  the 
peak  of  exercise,  and  60  min  after  completion  of  the  exercise 
test.  In  contrast,  we  collected  blood  samples  before  the 
application of stress and 5 min after the exercise ECG test. Even 
with  this  difference  in  blood  sampling,  we  obtained  the  same 
results  regarding  the  response  of  serum  IMA  to  exercise.  This 
implies  that  the  serum  IMA  level  is  not  an  useful  marker  of 
ischemia  in  patients  with  stable  angina.  Another  study  also 
suggested that  the  elevation  of  lactate  level  during  the  exercise 
may  influence  the  serum  IMA  level,  which  could  account  for 
reduced serum IMA level after exercise
17). Consistent with these 
studies, the serum lactate level in our study showed an excellent 
correlation  with  the  serum  IMA  level.  However,  since  our  study 
was  not  designed  to  elucidate  the  exact  mechanism  of  the 
response  of  IMA  to  exercise-induced  myocardial  ischemia,  our 
result showing a relationship between lactate and IMA should be 
used  only  to  verify  the  report  of  Zapico-Muniz
17).  In  conclusion, 
no  other diagnostic  usefulness  of  the  IMA  level  could  be  found 
i n  t h e  s e t t i n g  o f  s y m p t o m - l i m i t e d  e x e r c i s e .  T h e s e  f i n d i n g s  m a y  
support the caution for IMA to be used to determine ischemia in 
patients  with  stable  angina.
Study  Limitations
This study has several limitations. First, the number of patients 
studied  was  relatively  small.  Second,  in  the  symptom-  limited 
exercise  ECG  test,  26.9  and  28.6%  of  the  patients  in  the 
non-CAD  and  CAD  groups,  respectively,  did  not  reach  a 
sufficient  exercise  level  (≥  85%  of  the  maximum  HR)  or  ECG 
change during the exercise period, meaning that a portion of the 
CAD  group  may  not  have  developed  exercise-induced 
myocardial  ischemia,  which  could  have  affected  our  results. 
T h e r e f o r e ,  o u r  r e s u l t s  s h o u l d  b e  a p p l i e d  o n l y  t o  s y m p t o m -  
limited  exercise  stress  tests;  moreover,  additional  studies  with 
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level  in  terms  of  myocardial  ischemia  during  exercise.  Third,  in 
the  TMT  positive  and  negative  groups,  patient  age  was  not 
matched  between  the  two  groups,  although  the  parameters  of 
sex,  METs  achieved,  and  achieved  HR  over  the  predicted 
maximum  HR  (%)  were  matched.  This  could  have  affected  our 
results. Fourth, we did not examine the change in IMA long after 
exercise  (e.g.,  1  h  later).  Instead,  we  considered  only  two  time 
points  (before  exercise  and  5  min  after  exercise),  which  means 
that the time window of this study might not be long enough to 
reveal  the  entire  effect  of  exercise  on  the  IMA  plasma  level. 
Finally,  if  we  had  analyzed  other  biochemical  parameters  to 
elucidate  the  underlying  mechanism  of  IMA    change  during 
exercise,  we  might  have  been  able  to  suggest  a  possible 
mechanism  using  statistical  approaches,  such  as  regression 
analysis. Further study is needed to better understand this point.
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